Topic:

Cancer

Latest Headlines

Latest Headlines

UC Irvine investigators feature a new class of 'chemosensitizers'

Scientists with the UC Irvine School of Medicine and the Italian Institute of Technology have spotlighted what they call the "very first class" of acid ceramidase inhibitors that could eventually go on to help amp up the effectiveness of chemotherapies.

UC Irvine investigators spotlight a new class of 'chemosensitizers'

Scientists with the UC Irvine School of Medicine and the Italian Institute of Technology have spotlighted what they call the "very first class" of acid ceramidase inhibitors that could eventually go on to help amp up the effectiveness of chemotherapies.

Knocking out a pair of genes may help prevent a relapse of leukemia

Working around the notion that cancer-causing mutations on receptors found in bone marrow stem cells could explain why some patients grow resistant to currently used leukemia drugs, researchers at the Indiana University School of Medicine say they've been successful in testing a new approach to fighting the disease.

Study: Myriad skin cancer Dx shows reduction in indeterminate diagnoses

Myriad Genetics said results from a study of its myPath Melanoma test showed a 43% reduction in indeterminate diagnoses of skin cancer and nearly a 50% change by doctors in their treatment recommendations for patients.

Google signs on to Foundation Medicine cancer Dx by offering tests to employees

Diagnostics luminary Foundation Medicine is generating some upward momentum, fueled by growing revenues and the success of its clinical tests. Tech giant Google has taken note and is signing onto the company's cancer diagnostics by offering them to employees.  

Cleveland Clinic crew identifies possible lung cancer biomarkers

Cleveland Clinic scientists believe they have identified possible blood biomarkers that could help detect lung cancer, based on the alteration of metabolic processes that happens to patients with the disease at various stages.

BioMérieux subsidiary nails Medicare coverage for breast cancer molecular test

A subsidiary of French in vitro diagnostics giant bioMérieux gained Medicare coverage for a new breast cancer test, a vital milestone necessary to compete in today's market.

Celgene takes equity stake in Sequenta and its precise Dx tech

Sequenta attracted new equity investment from Celgene and other unnamed parties that back the use of its technology in the drug development process and the creation of new ultraprecise diagnostic tests.

Biocept, Rosetta Genomics want to beef up Dx and biomarker-detection power

Biocept forged a partnership deal with a competitor that aims to build an enhanced molecular diagnostics test for circulating tumor cells in the blood. Success could breed a more precise test that aids patient diagnoses and drug development in equal measure.

Wellcome Trust, Merck Serono collaborate on cancer drug discovery

Merck Serono is teaming up with London's Institute of Cancer Research and the charitable Wellcome Trust to identify and develop new inhibitors to treat cancer.